Addus HomeCare Corporation (NASDAQ:ADUS) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

Key Points

• Wall Street rates Addus HomeCare a “Moderate Buy”: Seven of 12 analysts recommend buying, four rate it hold and one recommends selling; the average 12-month price target is $134.70.
• Quarterly results were mixed: Earnings of $1.83 per share topped the $1.79 consensus, and revenue grew 7% year over year, but revenue of $387.74 million fell slightly short of estimates.
• UBS raised its price target to $160 and TD Cowen to $145, both maintaining Buy ratings. Addus expects to close its AccentCare acquisition in the first quarter of 2027 and projects an adjusted EBITDA margin of about 13% for the full year.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $134.70.

Several equities research analysts have commented on ADUS shares. Raymond James Financial set a $137.00 price objective on shares of Addus HomeCare in a report on Monday, September 28th. Wall Street Zen upgraded Addus HomeCare from a "buy" rating to a "strong-buy" rating in a report on Saturday. Barclays increased their target price on Addus HomeCare from $96.00 to $101.00 and gave the stock an "underweight" rating in a research note on Wednesday. UBS Group boosted their price objective on Addus HomeCare from $145.00 to $160.00 and gave the company a "buy" rating in a research report on Thursday. Finally, Citigroup lowered shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a research note on Monday, September 14th.

Addus HomeCare Stock Performance

ADUS opened at $124.31 on Friday. The firm has a fifty day moving average price of $117.60 and a 200 day moving average price of $106.88. The stock has a market cap of $2.32 billion, a P/E ratio of 20.72, a P/E/G ratio of 1.79 and a beta of 0.75. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $131.59.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, beating analysts' consensus estimates of $1.79 by $0.04. The firm had revenue of $387.74 million for the quarter, compared to analysts' expectations of $388.72 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.56 earnings per share. Equities research analysts anticipate that Addus HomeCare will post 6.34 earnings per share for the current year.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: UBS raised its price target to $160 from $145 and maintained a Buy rating; TD Cowen lifted its target to $145 from $131 and also maintained a Buy rating. UBS price-target report TD Cowen price-target report
• Positive Sentiment: ADUS recently reached a 52-week high. Its latest quarterly results included earnings per share of $1.83, ahead of the $1.79 consensus, while revenue increased 7% year over year. Addus hits a 12-month high
• Positive Sentiment: The company said it expects to close its AccentCare acquisition in the first quarter of 2027 and anticipates a full-year adjusted EBITDA margin around 13%; the deal may offer a growth opportunity, though execution remains ahead. AccentCare update
• Neutral Sentiment: Recent Zacks pieces discuss ADUS’s momentum and value-investing appeal, but the available summaries do not provide specific ratings or new estimates. Zacks momentum article Zacks value article
• Negative Sentiment: Quarterly revenue of $387.74 million was slightly below analysts’ $388.72 million estimate, tempering the otherwise positive earnings beat. Q3 earnings call highlights

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently made changes to their positions in ADUS. Nisa Investment Advisors LLC lifted its holdings in Addus HomeCare by 16.9% in the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company's stock valued at $85,000 after acquiring an additional 111 shares during the last quarter. Assenagon Asset Management S.A. grew its stake in shares of Addus HomeCare by 2.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company's stock valued at $593,000 after purchasing an additional 114 shares during the period. Janney Montgomery Scott LLC increased its stake in Addus HomeCare by 1.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 12,254 shares of the company's stock worth $1,148,000 after purchasing an additional 132 shares in the last quarter. Net Worth Advisory Group increased its stake in Addus HomeCare by 4.1% during the 3rd quarter. Net Worth Advisory Group now owns 3,419 shares of the company's stock worth $382,000 after acquiring an additional 136 shares during the period. Finally, Hohimer Wealth Management LLC increased its holdings in Addus HomeCare by 5.4% in the third quarter. Hohimer Wealth Management LLC now owns 2,809 shares of the company's stock worth $311,000 after purchasing an additional 143 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Inc NASDAQ: ADUS provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company's personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.